PDL BIOPHARMA, INC. 4
4 · PDL BIOPHARMA, INC. · Filed Apr 23, 2007
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Exercise/Conversion
Common Stock
2007-04-20$17.13/sh+645$11,049→ 645 total - Sale
Common Stock
2007-04-20$23.87/sh−64$1,528→ 581 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2007-04-20−645→ 25,195 totalExercise: $17.13Exp: 2013-07-20→ Common Stock (645 underlying) - Sale
Common Stock
2007-04-20$23.98/sh−133$3,189→ 384 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Option vests with respect to approximately 645 shares per month and 7 shares remained exercisable immediately after this transaction. Only vested options are exercisable